Login / Signup

Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5.

Zsuzsanna Bago-HorvathMargaretha RudasChristian F SingerRichard GreilMarija BalićSigurd F LaxWerner KwasnyWolfgang HullaMichael GnantMartin Filipits
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
Determination of molecular subtypes by IHC is an independent prognostic factor for recurrence and death in premenopausal women with early-stage, hormone receptor-positive breast cancer but is not predictive for outcome of adjuvant treatment with tamoxifen/goserelin or CMF.See related commentary by Hunter et al., p. 5543.
Keyphrases